ID   FABP6_HUMAN             Reviewed;         128 AA.
AC   P51161; Q07DR7; Q8TBI3; Q9UGI7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Gastrotropin;
DE            Short=GT;
DE   AltName: Full=Fatty acid-binding protein 6;
DE   AltName: Full=Ileal lipid-binding protein;
DE            Short=ILBP;
DE   AltName: Full=Intestinal 15 kDa protein;
DE            Short=I-15P;
DE   AltName: Full=Intestinal bile acid-binding protein;
DE            Short=I-BABP;
GN   Name=FABP6; Synonyms=ILBP, ILLBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Ileum;
RX   PubMed=7619861; DOI=10.1016/0005-2760(95)00098-W;
RA   Oelkers P., Dawson P.A.;
RT   "Cloning and chromosomal localization of the human ileal lipid-binding
RT   protein.";
RL   Biochim. Biophys. Acta 1257:199-202(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), BILE ACID-BINDING, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Ileum;
RX   PubMed=7588781; DOI=10.1111/j.1432-1033.1995.406_2.x;
RA   Fujita M., Fujii H., Kanda T., Sato E., Hatakeyama K., Ono T.;
RT   "Molecular cloning, expression, and characterization of a human
RT   intestinal 15-kDa protein.";
RL   Eur. J. Biochem. 233:406-413(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION (ISOFORM 2),
RP   ALTERNATIVE PROMOTER USAGE, SUBCELLULAR LOCATION, INDUCTION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=17909007; DOI=10.1158/0008-5472.CAN-06-3690;
RA   Fang C., Dean J., Smith J.W.;
RT   "A novel variant of ileal bile acid binding protein is up-regulated
RT   through nuclear factor-kappaB activation in colorectal
RT   adenocarcinoma.";
RL   Cancer Res. 67:9039-9046(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND
RP   VARIANTS HIS-33 AND TYR-55.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-19 (ISOFORM 1).
RA   Barley N.F., Shaw-Smith C.J., Chakravarty P., Howard A., Legon S.,
RA   Walters J.R.;
RT   "The human ileal bile acid binding protein gene: promoter sequence and
RT   effects of CDX2 on expression.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   BILE ACID-BINDING.
RX   PubMed=11461829; DOI=10.1016/S1357-2725(01)00070-X;
RA   Zimmerman A.W., van Moerkerk H.T., Veerkamp J.H.;
RT   "Ligand specificity and conformational stability of human fatty acid-
RT   binding proteins.";
RL   Int. J. Biochem. Cell Biol. 33:865-876(2001).
RN   [8]
RP   STRUCTURE BY NMR IN COMPLEX WITH TAUROCHOLATE, AND DOMAIN.
RX   PubMed=12486725; DOI=10.1002/prot.10289;
RA   Kurz M., Brachvogel V., Matter H., Stengelin S., Thuering H.,
RA   Kramer W.;
RT   "Insights into the bile acid transportation system: the human ileal
RT   lipid-binding protein-cholyltaurine complex and its comparison with
RT   homologous structures.";
RL   Proteins 50:312-328(2003).
RN   [9]
RP   STRUCTURE BY NMR IN COMPLEX WITH GLYCOCHOLATE AND
RP   GLYCOCHENODEOXYCHOLATE, AND DOMAIN.
RX   PubMed=26613247; DOI=10.1111/febs.13610;
RA   Horvath G., Bencsura A., Simon A., Tochtrop G.P., DeKoster G.T.,
RA   Covey D.F., Cistola D.P., Toke O.;
RT   "Structural determinants of ligand binding in the ternary complex of
RT   human ileal bile acid binding protein with glycocholate and
RT   glycochenodeoxycholate obtained from solution NMR.";
RL   FEBS J. 283:541-555(2016).
RN   [10]
RP   VARIANT MET-79.
RX   PubMed=19744871; DOI=10.1016/j.ymgme.2009.08.001;
RA   Fisher E., Grallert H., Klapper M., Pfaefflin A., Schrezenmeir J.,
RA   Illig T., Boeing H., Doering F.;
RT   "Evidence for the Thr79Met polymorphism of the ileal fatty acid
RT   binding protein (FABP6) to be associated with type 2 diabetes in obese
RT   individuals.";
RL   Mol. Genet. Metab. 98:400-405(2009).
CC   -!- FUNCTION: Binds to bile acids and is involved in enterohepatic
CC       bile acid metabolism. Required for efficient apical to basolateral
CC       transport of conjugated bile acids in ileal enterocytes (By
CC       similarity). In vitro binds to bile acids in the order:
CC       deoxycholic acid > cholic acid > chenodeoxycholic acid and
CC       respective BA conjugation modifies affinities in the order
CC       taurine-conjugated > glycine-conjugated > unconjugated bile acids.
CC       Stimulates gastric acid and pepsinogen secretion (By similarity).
CC       {ECO:0000250|UniProtKB:P10289, ECO:0000250|UniProtKB:P51162,
CC       ECO:0000269|PubMed:12486725, ECO:0000269|PubMed:7588781}.
CC   -!- FUNCTION: Isoform 2: Essential for the survival of colon cancer
CC       cells to bile acid-induced apoptosis.
CC       {ECO:0000269|PubMed:17909007}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm
CC       {ECO:0000250|UniProtKB:P80020}. Membrane; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:P50119}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P50119}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:17909007}. Note=Localized close to nucleus on
CC       the apical side of both normal and neoplastic cells.
CC       {ECO:0000269|PubMed:17909007}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51161-1; Sequence=Displayed;
CC       Name=2; Synonyms=IBABP-L;
CC         IsoId=P51161-2; Sequence=VSP_038039;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in the jejunum, ileum,
CC       cecum and ascending colon intestine. Isoform 2 is xpressed in the
CC       gallbladder, duodenum, jejunum, ileum, cecum, ascending,
CC       transverse and descending colon, sigmoid colon and rectum. Isoform
CC       2 is expressed in colorectal adenocarcinomas and their adjacent
CC       normal mucosa (at protein level). {ECO:0000269|PubMed:17909007,
CC       ECO:0000269|PubMed:7588781, ECO:0000269|PubMed:7619861}.
CC   -!- INDUCTION: Isoform 1 is up-regulated by chenodeoxycholic acid
CC       (CDCA) via the FXR transcription pathway. Isoform 2 is up-
CC       regulated by NF-kappa-B and in all stages of colorectal
CC       adenocarcinoma. Isoform 1 is not up-regulated in all stages of
CC       colorectal adenocarcinoma. {ECO:0000269|PubMed:17909007}.
CC   -!- DOMAIN: Forms a beta-barrel structure that accommodates the
CC       hydrophobic ligand in its interior. Can bind at least two ligands
CC       per molecule, however, the stoichiometry is debated.
CC       {ECO:0000305|PubMed:12486725, ECO:0000305|PubMed:26613247}.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Fatty-acid binding
CC       protein (FABP) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22489.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U19869; AAB82751.1; -; mRNA.
DR   EMBL; X90908; CAA62415.1; -; mRNA.
DR   EMBL; DQ132786; ABA12611.1; -; mRNA.
DR   EMBL; AC008609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112191; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022489; AAH22489.1; ALT_INIT; mRNA.
DR   EMBL; AJ250902; CAB65728.1; -; Genomic_DNA.
DR   CCDS; CCDS43393.1; -. [P51161-2]
DR   CCDS; CCDS4349.1; -. [P51161-1]
DR   PIR; S63983; S63983.
DR   RefSeq; NP_001035532.1; NM_001040442.1. [P51161-2]
DR   RefSeq; NP_001124430.1; NM_001130958.1. [P51161-2]
DR   RefSeq; NP_001436.1; NM_001445.2. [P51161-1]
DR   UniGene; Hs.519719; -.
DR   PDB; 1O1U; NMR; -; A=2-128.
DR   PDB; 1O1V; NMR; -; A=2-128.
DR   PDB; 2MM3; NMR; -; A=2-128.
DR   PDB; 5L8I; X-ray; 1.88 A; A/B/C=1-128.
DR   PDB; 5L8N; X-ray; 2.12 A; A/B/C=1-128.
DR   PDB; 5L8O; X-ray; 2.39 A; A/B/C=1-128.
DR   PDBsum; 1O1U; -.
DR   PDBsum; 1O1V; -.
DR   PDBsum; 2MM3; -.
DR   PDBsum; 5L8I; -.
DR   PDBsum; 5L8N; -.
DR   PDBsum; 5L8O; -.
DR   ProteinModelPortal; P51161; -.
DR   SMR; P51161; -.
DR   STRING; 9606.ENSP00000377549; -.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB02691; N-Cholylglycine.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   SwissLipids; SLP:000001518; -.
DR   iPTMnet; P51161; -.
DR   PhosphoSitePlus; P51161; -.
DR   BioMuta; FABP6; -.
DR   DMDM; 1708457; -.
DR   MaxQB; P51161; -.
DR   PaxDb; P51161; -.
DR   PeptideAtlas; P51161; -.
DR   PRIDE; P51161; -.
DR   DNASU; 2172; -.
DR   Ensembl; ENST00000393980; ENSP00000377549; ENSG00000170231. [P51161-2]
DR   Ensembl; ENST00000402432; ENSP00000385433; ENSG00000170231. [P51161-1]
DR   GeneID; 2172; -.
DR   KEGG; hsa:2172; -.
DR   UCSC; uc003lxx.2; human. [P51161-1]
DR   CTD; 2172; -.
DR   DisGeNET; 2172; -.
DR   GeneCards; FABP6; -.
DR   HGNC; HGNC:3561; FABP6.
DR   HPA; CAB024713; -.
DR   HPA; HPA012601; -.
DR   MalaCards; FABP6; -.
DR   MIM; 600422; gene.
DR   neXtProt; NX_P51161; -.
DR   OpenTargets; ENSG00000170231; -.
DR   PharmGKB; PA27962; -.
DR   eggNOG; KOG4015; Eukaryota.
DR   eggNOG; ENOG4111US8; LUCA.
DR   GeneTree; ENSGT00390000012034; -.
DR   HOGENOM; HOG000004830; -.
DR   HOVERGEN; HBG005633; -.
DR   InParanoid; P51161; -.
DR   KO; K08755; -.
DR   OMA; TVKMEGG; -.
DR   OrthoDB; EOG091G16BV; -.
DR   PhylomeDB; P51161; -.
DR   TreeFam; TF330348; -.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   ChiTaRS; FABP6; human.
DR   EvolutionaryTrace; P51161; -.
DR   GeneWiki; FABP6; -.
DR   GenomeRNAi; 2172; -.
DR   PRO; PR:P51161; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170231; -.
DR   CleanEx; HS_FABP6; -.
DR   ExpressionAtlas; P51161; baseline and differential.
DR   Genevisible; P51161; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032052; F:bile acid binding; IEA:InterPro.
DR   GO; GO:0008289; F:lipid binding; TAS:ProtInc.
DR   GO; GO:0005215; F:transporter activity; IEA:InterPro.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0008206; P:bile acid metabolic process; IEA:InterPro.
DR   GO; GO:0006629; P:lipid metabolic process; NAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0019433; P:triglyceride catabolic process; TAS:Reactome.
DR   Gene3D; 2.40.128.20; -; 1.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR000463; Fatty_acid-bd.
DR   InterPro; IPR031257; Gastrotropin.
DR   InterPro; IPR031259; ILBP.
DR   PANTHER; PTHR11955; PTHR11955; 1.
DR   PANTHER; PTHR11955:SF115; PTHR11955:SF115; 1.
DR   PRINTS; PR00178; FATTYACIDBP.
DR   SUPFAM; SSF50814; SSF50814; 1.
DR   PROSITE; PS00214; FABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative promoter usage;
KW   Complete proteome; Cytoplasm; Lipid transport; Lipid-binding;
KW   Membrane; Polymorphism; Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P10289}.
FT   CHAIN         2    128       Gastrotropin.
FT                                /FTId=PRO_0000067380.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P10289}.
FT   VAR_SEQ       1      1       M -> MKTVTMMMVVEMQALTQVLRAVLSACTWVSRKGDLQ
FT                                RMKQTHKGKPPSSM (in isoform 2).
FT                                {ECO:0000303|PubMed:17909007}.
FT                                /FTId=VSP_038039.
FT   VARIANT      33     33       R -> H (in dbSNP:rs17856662).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_039578.
FT   VARIANT      55     55       S -> Y (in dbSNP:rs17852045).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_039579.
FT   VARIANT      79     79       T -> M (may be associated with type 2
FT                                diabetes obese individuals;
FT                                dbSNP:rs1130435).
FT                                {ECO:0000269|PubMed:19744871}.
FT                                /FTId=VAR_039580.
FT   STRAND        5     14       {ECO:0000244|PDB:5L8I}.
FT   HELIX        15     22       {ECO:0000244|PDB:5L8I}.
FT   HELIX        26     33       {ECO:0000244|PDB:5L8I}.
FT   STRAND       37     44       {ECO:0000244|PDB:5L8I}.
FT   STRAND       47     54       {ECO:0000244|PDB:5L8I}.
FT   TURN         55     57       {ECO:0000244|PDB:5L8O}.
FT   STRAND       59     65       {ECO:0000244|PDB:5L8I}.
FT   STRAND       68     72       {ECO:0000244|PDB:5L8I}.
FT   STRAND       75     77       {ECO:0000244|PDB:5L8N}.
FT   STRAND       80     83       {ECO:0000244|PDB:5L8I}.
FT   STRAND       85     87       {ECO:0000244|PDB:5L8I}.
FT   STRAND       90     95       {ECO:0000244|PDB:5L8I}.
FT   STRAND       98    104       {ECO:0000244|PDB:5L8I}.
FT   STRAND      106    115       {ECO:0000244|PDB:5L8I}.
FT   STRAND      118    127       {ECO:0000244|PDB:5L8I}.
SQ   SEQUENCE   128 AA;  14371 MW;  173CBC5DBEDADDE1 CRC64;
     MAFTGKFEME SEKNYDEFMK LLGISSDVIE KARNFKIVTE VQQDGQDFTW SQHYSGGHTM
     TNKFTVGKES NIQTMGGKTF KATVQMEGGK LVVNFPNYHQ TSEIVGDKLV EVSTIGGVTY
     ERVSKRLA
//
